What is NDC 70700-315?

70700-315 is the product NDC for Medroxyprogesterone Acetate, Medroxyprogesterone acetate 150 mg/mL injection, suspension, listed with the FDA by Xiromed LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Xiromed LLC, NDC labeler code 70700. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Medroxyprogesterone Acetate?

39 other product NDCs are listed under this name.

Medroxyprogesterone Acetate NDC 70700-315

NDC codes

FDA NDC Directory

Product NDC (as listed)70700-315Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70700-0315Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70700-315-25	7070003152570700031525	25 VIAL in 1 CARTON (70700-315-25) / 1 mL in 1 VIAL (70700-315-22)Marketed from Mar 12, 2024
70700-315-27	7070003152770700031527	1 VIAL in 1 CARTON (70700-315-27) / 1 mL in 1 VIAL (70700-315-22)Marketed from Mar 12, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Medroxyprogesterone Acetate
Generic name (nonproprietary): medroxyprogesterone acetate
Active ingredients: Medroxyprogesterone acetate — 150 mg/mL
Dosage form: Injection, Suspension
Route: Intramuscular
Labeler: Xiromed LLCNDC labeler code 70700
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210227
Marketing start: Mar 12, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Progesterone Congeners (Chemical structure)
Identifiers: Product ID 70700-315_1a9d4cef-846b-2f23-65e1-7d4d4231f1ccSPL ID 1a9d4cef-846b-2f23-65e1-7d4d4231f1ccSPL set ID 24544a5d-0cf5-a099-b57c-6e0843a40532RxCUI 1000126UNII C2QI4IOI2G
Pharmacologic class: Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J1050 — Injection, medroxyprogesterone acetate, 1 mg

Billing unit: 1 mg. Units on the claim = dose given ÷ 1 mg.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470700031525 followed by a unit qualifier and the quantity

Package 70700-0315-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 13, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ]. Medroxyprogesterone acetate injectable suspension is a progestin indicated for use by females of reproductive potential to prevent pregnancy. ( 1 ) Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70700-315

What is NDC 70700-315?: 70700-315 is the product NDC for Medroxyprogesterone Acetate, Medroxyprogesterone acetate 150 mg/mL injection, suspension, listed with the FDA by Xiromed LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Medroxyprogesterone Acetate.
What is the active ingredient?: Medroxyprogesterone acetate.
Who is the labeler?: Xiromed LLC, NDC labeler code 70700. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Medroxyprogesterone Acetate?: 39 other product NDCs are listed under this name. See all Medroxyprogesterone Acetate NDCs.
Is there a related HCPCS / J-code?: Yes: J1050, Injection, medroxyprogesterone acetate, 1 mg. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Medroxyprogesterone Acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 2.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4666	70518-4666-0070518-4666-02
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Amneal Pharmaceuticals NY LLC	60219-1467	60219-1467-0160219-1467-02
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	REMEDYREPACK INC.	70518-4324	70518-4324-00
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 2.5 mg/1	TabletOral	Coupler LLC	67046-1480	67046-1480-03
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 10 mg/1	TabletOral	Northwind Health Company, LLC	51655-520	51655-0520-52
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Amneal Pharmaceuticals LLC	70121-1467	70121-1467-0270121-1467-05
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Amneal Pharmaceuticals LLC	70121-1480	70121-1480-01
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Eugia US LLC	55150-330	55150-0330-01
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Eugia US LLC	55150-329	55150-0329-0155150-0329-25
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8112	68788-8112-0168788-8112-03

All 40 Medroxyprogesterone Acetate NDCs

Other NDCs under ANDA 210227

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210227
Product	Strength	Form · route	Labeler	Product NDC
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Amneal Pharmaceuticals NY LLC	60219-1467
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Mylan Institutional LLC	67457-887